Valuation: Aptahem AB

Chart: Aptahem AB

Timeframe

Style

06-17	Aptahem Improves Quality And Manufacturing Efficiency In A New Apta-1 Test Batch	CI
06-17	Aptahem Reports Improved Production of Apta-1	FW
05-28	Aptahem AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-28	Aptahem reports narrowed operating loss	FW
05-11	Aptahem to focus on conditions mirroring sepsis pathology - newsletter	FW
04-28	Aptahem finalizes rights issue results - subscribed to 23.7 percent	FW
04-24	Aptahem raises SEK 3.3 million in undersubscribed rights issue - preliminary figures	FW
04-07	Aptahem shares trade ex-rights on Spotlight today following rights issue	FW
03-27	Aptahem announces rights issue of approximately SEK 13.8 million	FW
02-26	Aptahem AB Auditor Raises 'Going Concern' Doubt	CI
02-25	Aptahem Proposes Election of Brian Packard to the Board	FW
02-12	Aptahem Reports Minor Changes in Results – Data Room Activity at Record High	FW
02-12	Aptahem AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI

25-09-19

06-17	Aptahem: Aptahem Improves Quality and Manufacturing Efficiency in a New Apta-1 Test Batch	PU
06-17	Aptahem Improves Quality and Manufacturing Efficiency in a New Apta-1 Test Batch	AQ
06-05	Aptahem: Aptahem to Participate at IOPC 2026 in Athens	PU
06-05	Aptahem to Participate at IOPC 2026 in Athens	AQ
05-11	Aptahem: Newsletter May 2026	PU

Manager	Title	Age	Since
Luiza Jedlina CTO	Chief Tech/Sci/R&D Officer	-	2016-02-29
Knut Mikael Ingolf Lindstam CEO	Chief Executive Officer	60	2013-12-31
Ola Skanung DFI	Director of Finance/CFO	62	-

Director	Title	Age	Since
Knut Mikael Ingolf Lindstam BRD	Director/Board Member	60	2013-12-31
Johan Lindh BRD	Director/Board Member	-	-
Ulla Cristina Glad BRD	Director/Board Member	74	2016-05-31

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
APTAHEM AB	-4.29%	+5.76%	-46.44%	-97.53%	1.69M
ARGENX SE	+1.44%	-1.25%	+63.52%	+114.88%	55.19B
WUXI APPTEC CO., LTD.	+4.60%	+3.02%	+58.20%	+47.16%	45.75B
BIONTECH SE	-1.44%	+0.39%	-12.94%	-19.24%	22.98B
INSMED INCORPORATED	-2.69%	-2.10%	-3.68%	+379.00%	20.76B
WUXI BIOLOGICS (CAYMAN) INC.	+3.22%	-0.84%	+27.88%	-34.00%	16.26B
GENMAB A/S	+0.58%	+1.08%	+16.73%	-38.06%	15.42B
EXELIXIS, INC.	-1.01%	-2.30%	+27.42%	+171.92%	13.05B
PHARMAESSENTIA CORPORATION	+4.95%	+11.70%	+123.63%	+252.19%	12.45B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+3.07%	+0.14%	+29.37%	-	12.37B
Average	+0.84%	+2.58%	+28.37%	+86.26%	21.42B
Weighted average by Cap.	+1.63%	+1.48%	+40.92%	+99.91%